INS and type 2 diabetes mellitus: In summary, our study shows that thrice daily inhaled insulin administration effectively reduced the fasting and postprandial plasma glucose concentrations and markedly improved glycemic control (ΔHbA1c = −2.8%) in poorly controlled T2D patients by augmenting tissue sensitivity to insulin and enhancing beta cell function.